Congressman Mike Kelly—the lawmaker blocking access to critical documents about the Butler assassination attempt—must not be allowed to advance a bill that ignores glaring conflicts of interest in behavioral health linked to the Butler, PA assassination attempt of President Trump. KILL THE BILL: HR 2085
Key Connections Being Hidden:
- Crooks’ Parents & Behavioral Health Influence: Investigative documents withheld by Kelly’s office may reveal ties between Thomas Crooks’ parents (behavioral health “experts”) and entities like Genesis HealthCare, which employed Crooks at its Bethel Park facility.
- Genesis HealthCare’s Reach: A major behavioral health and nursing home provider, Genesis has subsidiaries spanning 19 states and investors linked to behavioral health tech firms.
Morgan Lewis & Bockius LLP represented Genesis in these matters. What is stunning about the law firm that rescued Bethel Skilled Nursing home from Department of Justice inquiries was that Morgan Lewis & Bockius LLP is deeply entrenched in the psychiatric drug sector.
The firm has extensive ties to pharmaceutical companies. In fact, the firm handled one of the largest psychotropic drug settlements in United States history in 2017, M.B. v. Tidball, on behalf of a group of nonprofits that the firm also just happens to represent.
The results of this insider settlement by vested stakeholders, psychotropic drugging continues to skyrocket. Big Pharma and the Behavioral Health Industrial Complex was able to walk away from any accountability without losing access to children in State care.
- AGR Building Investors: The AGR Building is reportedly tied to stakeholders in behavioral health technology—a sector incentivized by bills like H.R. 2085, which lacks ethical guardrails.
Roper Technologies retains a 49% minority stake in Indicor, the industrial company that owns the AGR Building in Butler, PA, through its subsidiary AGR International.
Simultaneously, Roper is aggressively expanding into behavioral health with its pending $1.65 billion acquisition of CentralReach, a leading provider of cloud-based software for Applied Behavior Analysis (ABA) therapy serving autism and intellectual/developmental disabilities (IDD).
CentralReach is projected to generate $175 million in revenue and $75 million in EBITDA for the fiscal year ending June 2026, reflecting Roper’s focus on high-growth, tech-enabled healthcare solutions.
Hellbound and Down 